Certara: Still Awaiting Consistent Growth (NASDAQ:CERT)
Olga Seifutdinova/iStock via Getty Images It has been nearly 11 months since our last look at Certara, Inc. (NASDAQ:CERT). This small-cap concern has somewhat of a unique niche in drug development. We concluded our last article on this name saying […]
Certara: Still Awaiting Consistent Growth (NASDAQ:CERT) Read More »